Rochal Industries, San Antonio, Texas.
iFyber, Ithaca, New York.
Wound Manag Prev. 2020 Nov;66(11):31-42.
Biofilms are believed to be a source of chronic inflammation in non-healing wounds.
In this study, the pre-clinical anti-biofilm efficacy of several wound cleansers was examined using the Calgary minimum biofilm eradication concentration (MBEC) and ex vivo porcine dermal explant (PDE) models on Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA), and Candida albicans biofilms.
A surfactant-based cleanser and antimicrobial-based cleansers containing ionic silver, hypochlorous acid (HOCl), sodium hypochlorite (NaOCl), and polyhexamethylene biguanide (PHMB) were tested on the MBEC model biofilms with a 10-minute application time. Select cleansers were then tested on the mature PDE biofilms with 10-minute applications followed by the application of cleanser-soaked gauze. The PDE model was further expanded to include single and daily applications of the cleansers to mimic daily and 72-hour dressing changes.
In the MBEC model, PHMB- and HOCl-based cleansers reduced immature MRSA, C albicans, and P aeruginosa biofilm regrowth by > 3× when compared with silver, surfactant, and saline cleansers. The major differences could be elucidated in the PDE model in which, after daily application, 1 PHMB-based cleanser showed a statistically significant reduction (3-8 CFU/mL log reduction) in all mature biofilms tested, while a NaOCl-based cleanser showed significant reduction in 2 microorganisms (3-5 CFU/mL log reduction, P aeruginosa and MRSA).The other PHMB-based cleanser showed a statistically significant 3 log CFU/mL reduction in P aeruginosa. The remaining cleansers showed no statistically significant difference from the saline control.
Results confirm that there are model-dependent differences in the outcomes of these studies, suggesting the importance of model selection for product screening. The results indicate that 1 PHMB-based cleanser was effective in reducing mature P aeruginosa, MRSA, and C albicans biofilms and that sustained antimicrobial presence was necessary to reduce or eliminate these mature biofilms.
本研究采用卡尔加里最低生物膜清除浓度(MBEC)和体外猪皮真皮(PDE)模型,检测了几种伤口清洁剂在铜绿假单胞菌、耐甲氧西林金黄色葡萄球菌(MRSA)和白色念珠菌生物膜中的临床前抗生物膜效果。
用一种基于表面活性剂的清洁剂和一种含有离子银、次氯酸(HOCl)、次氯酸钠(NaOCl)和聚六亚甲基双胍(PHMB)的基于抗菌剂的清洁剂在 10 分钟应用时间的 MBEC 模型生物膜上进行测试。然后,选择的清洁剂在成熟的 PDE 生物膜上进行测试,应用 10 分钟,然后应用浸有清洁剂的纱布。PDE 模型进一步扩展到包括清洁剂的单次和每日应用,以模拟每日和 72 小时的换敷料。
在 MBEC 模型中,与银、表面活性剂和生理盐水清洁剂相比,基于 PHMB 和 HOCl 的清洁剂可使未成熟的 MRSA、C 白色念珠菌和 P 铜绿假单胞菌生物膜的再生长减少> 3×。在 PDE 模型中可以更清楚地阐明主要差异,其中,经过每日应用,1 种基于 PHMB 的清洁剂对所有测试的成熟生物膜显示出统计学上显著的减少(3-8 CFU/mL 对数减少),而基于 NaOCl 的清洁剂对 2 种微生物(P 铜绿假单胞菌和 MRSA 的 3-5 CFU/mL 对数减少)显示出显著减少。另一种基于 PHMB 的清洁剂对 P 铜绿假单胞菌显示出统计学上显著的 3 对数 CFU/mL 减少。其余清洁剂与生理盐水对照无统计学差异。
结果证实,这些研究的结果存在模型依赖性差异,这表明选择模型对于产品筛选很重要。结果表明,1 种基于 PHMB 的清洁剂可有效减少成熟的 P 铜绿假单胞菌、MRSA 和 C 白色念珠菌生物膜,并且需要持续存在抗菌剂才能减少或消除这些成熟的生物膜。